Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Rothbauer

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Life Science Alliance|May 30, 2024
Nanobodies as novel tools to monitor the mitochondrial fission factor Drp1Theresa Froehlich, Andreas Jenner, Claudia Cavarischia-Rega, et al.
EMBO Reports|December 20, 2021
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concernTeresa R Wagner, Daniel Schnepf, Julius Beer, et al.
Plos One|March 8, 2016
A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human CellsAndrea Buchfellner, Larisa Yurlova, Stefan Nüske, et al.
Frontiers in Immunology|October 30, 2024
Making the effect visible - OX40 targeting nanobodies for <i>in vivo</i> imaging of activated T cellsDesiree I Frecot, Simone Blaess, Teresa R Wagner, et al.
Cell Death & Disease|February 22, 2022
Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loopRomina J Walter, Steffen J Sonnentag, Leonel Munoz-Sagredo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2025
Noninvasive Monitoring of Inflammatory Processes by Myeloid Cell-Directed PET Tracers in an Experimental Severe Acute Respiratory Syndrome Coronavirus 2 Infection ModelMarieke A Stammes, Gerrit Koopman, Teresa R Wagner, et al.
Emerging Infectious Diseases|February 24, 2022
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA VaccinationAlex Dulovic, Monika Strengert, Gema Morillas Ramos, et al.
Ebiomedicine|August 14, 2021
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysisMonika Strengert, Matthias Becker, Gema Morillas Ramos, et al.
Biomed Research International|May 29, 2020
Systematic Investigation of Polyurethane Biomaterial Surface Roughness on Human Immune Responses <i>in vitro</i>Sören Segan, Meike Jakobi, Paree Khokhani, et al.
ACS Infectious Diseases|March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Life Science Alliance|May 30, 2024
Nanobodies as novel tools to monitor the mitochondrial fission factor Drp1Theresa Froehlich, Andreas Jenner, Claudia Cavarischia-Rega, et al.
EMBO Reports|December 20, 2021
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concernTeresa R Wagner, Daniel Schnepf, Julius Beer, et al.
Plos One|March 8, 2016
A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human CellsAndrea Buchfellner, Larisa Yurlova, Stefan Nüske, et al.
Frontiers in Immunology|October 30, 2024
Making the effect visible - OX40 targeting nanobodies for <i>in vivo</i> imaging of activated T cellsDesiree I Frecot, Simone Blaess, Teresa R Wagner, et al.
Cell Death & Disease|February 22, 2022
Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loopRomina J Walter, Steffen J Sonnentag, Leonel Munoz-Sagredo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2025
Noninvasive Monitoring of Inflammatory Processes by Myeloid Cell-Directed PET Tracers in an Experimental Severe Acute Respiratory Syndrome Coronavirus 2 Infection ModelMarieke A Stammes, Gerrit Koopman, Teresa R Wagner, et al.
Emerging Infectious Diseases|February 24, 2022
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA VaccinationAlex Dulovic, Monika Strengert, Gema Morillas Ramos, et al.
Ebiomedicine|August 14, 2021
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysisMonika Strengert, Matthias Becker, Gema Morillas Ramos, et al.
Biomed Research International|May 29, 2020
Systematic Investigation of Polyurethane Biomaterial Surface Roughness on Human Immune Responses <i>in vitro</i>Sören Segan, Meike Jakobi, Paree Khokhani, et al.
ACS Infectious Diseases|March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Pageof 11